Dysregulation of VHL, often resulting from gene mutations or deletions, is frequently observed in various cancers, including clear cell renal cell carcinoma (ccRCC), hemangioblastomas, and pheochromocytomas. Here, VHL is linked to nonpapillary renal cell carcinoma.